Back to ARK Investment Management LLC

CRSP
Showing 8 of 30 quarters

Position history for ARK Investment Management LLC's holdings in CRISPR THERAPEUTICS AG

ARK Investment Management LLC holds 11.3M shares of CRSP (CRISPR THERAPEUTICS AG), worth $538.2M as of 2026-Q1. The position was increased (+7.5% shares). CRSP represents 4.2% of ARK Investment Management LLC's portfolio.

Current Value

$538.2M

Current Shares

11.3M

Total Value Change

+$118.1M

Total Shares Change

+3.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
11.3M
+7.5%
$538.2M4.2%$58.06
62
2025-Q4
Increased
10.5M
+7.5%
$551.8M3.7%$53.19
62
2025-Q3
Decreased
9.8M
-3.9%
$634.3M3.8%$63.77
0
2025-Q2
Increased
10.2M
+0.2%
$495.3M3.6%$47.49
57
2025-Q1
Increased
10.2M
+13.3%
$345.9M3.5%$36.99
64
2024-Q4
Increased
9M
+19.7%
$353.2M2.9%$38.65
63
2024-Q3
Decreased
7.5M
-3.6%
$352.3M3.2%$47.32
0
2024-Q2
Decreased
7.8M
-4.6%
$420.1M3.7%$54.01
0

Other major holders of CRSP: Capital International Investors, Amova Asset Management Americas, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used